top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

2.120 +1.520 (+253.33%)
Delayed Quote Updated: 1:32 PM EST, Nov 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Why Inovio Pharmaceuticals (INO) Stock Is Down 40% ↗
Inovio Pharmaceuticals shares are trading lower by 38% during Friday's session. The company priced a public offering of 10 million shares of common stock and accompanying warrants. 
Via Benzinga
News headline image
US Stocks Likely To Open Higher, Investors Eye Fed Policy Meet Next Week: Broadcom, RH, Costco In Focus ↗
U.S. stock futures advanced on Friday in premarket after declining on Thursday. The futures of all four major indices were trading higher. 
Via Benzinga
Topics Economy
News headline image
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
RH, Broadcom And 3 Stocks To Watch Heading Into Friday ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals ↗
 
Via Benzinga
News headline image
A Preview Of Inovio Pharmaceuticals's Earnings ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
European And US Vaccine Stocks Are Under Pressure - Here's WHy ↗
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts. 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript ↗
INO earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Peering Into Inovio Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2024 ↗
 
Via Benzinga
News headline image
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
From FN Media Group LLC
Via GlobeNewswire
News headline image
Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript ↗
INO earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Better Buy: Inovio Pharmaceuticals vs. Novavax ↗
Both biotechs have been struggling for a while, but there might be some hope for them. 
Via The Motley Fool
News headline image
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst ↗
Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non-surgical RRP... 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript ↗
INO earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
INO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024 ↗
INO stock results show that Inovio Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy? ↗
Can the biotech succeed after a string of failures? 
Via The Motley Fool
News headline image
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. 
Via Benzinga
News headline image
Inovio Pharmaceuticals Stock Is Diving Today: What's Happening? ↗
Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693 per share. 
Via Benzinga
News headline image
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗
Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth diving into on Tuesday as we check out all of the biggest changes and the news behind them! 
Via InvestorPlace
News headline image
Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript ↗
INO earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023 ↗
INO stock results show that Inovio Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page